NEW YORK, May 27, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of LivePerson, Inc. (“LivePerson” or the “Company”) LPSN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, extension 7980.

The investigation addresses whether LivePerson and certain of its officers and/or directors have engaged in securities fraud or other illegal business practices.

[Click here for information about joining the class action]

On March 15, 2023, LivePerson issued a press release announcing its fourth quarter 2022 financial results, in which the company reported a decrease in loss and revenue. In its press release, LivePerson also announced that its subsidiary, WildHealth, has received notice that Medicare is suspending reimbursement of services under the Medicare Demonstration Program (the “Program”), under which certain non-core Medicare services are provided and reimbursed become . Accordingly, LivePerson stated that given the “inherent uncertainty as to the timing and amount of further reimbursements for program services,” the Company has decided to accrue a reserve for program service related revenue in the fourth quarter of 2022 which payment has not yet been collected.”

As a result of this news, LivePerson’s share price fell $5.64 per share, or 57.73%, to close at $4.13 per share on March 16, 2023.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris and Tel Aviv, is recognized as one of the leading law firms specializing in corporate, securities and antitrust litigation. Pomerantz was founded by the late Abraham L. Pomerantz, Dean of the Class Bar Association, and pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues the tradition he founded and fights for the rights of victims of securities fraud, fiduciary breaches and corporate wrongdoing. The Company…